Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Chemistry (Weinheim an Der Bergstrasse, Germany)|March 2, 2022
Metalloimmunotherapy with Rhodium and Ruthenium Complexes: Targeting Tumor-Associated MacrophagesNicholas Toupin, Mackenzie K Herroon, Randolph P Thummel, et al.
Endocrinology, Diabetes & Metabolism|January 16, 2025
Exploring the Predictive Role of 11-Oxyandrogens in Diagnosing Polycystic Ovary SyndromeArmaiti Parvez Mody, Maya Beth Lodish, Richard Joseph Auchus, et al.
Biorxiv : the Preprint Server for Biology|August 2, 2024
Ru(II)-Photoactive Agents for Targeting ER Stress and Immunogenic Cell DeathMadeline Denison, Alexander Ullrich, Mackenzie K Herroon, et al.
Journal of Outdoor Recreation and Tourism|July 31, 2023
COVID-19 compliance among urban trail users: Behavioral insights and environmental implicationsIngrid E Schneider, Megha Budruk, Kim Shinew, et al.
The Journal of Investigative Dermatology|March 26, 2015
Promoter-Specific Hypomethylation Is Associated with Overexpression of PLS3, GATA6, and TWIST1 in the Sezary SyndromeHenry K Wong, Heather Gibson, Timothy Hake, et al.
Journal of Outdoor Recreation and Tourism|July 31, 2023
Cases and context: Mask-related behaviors among U.S. trail visitors during the COVID-19 pandemicIngrid E Schneider, Christopher J Wynveen, Julian Wolfson, et al.
The American Surgeon|April 20, 2021
Chemotherapy and Abdominal Wall Closure Technique Increase the Probability of Postoperative Ventral Incisional Hernia in Patients With Colon CancerDavid A Santos, Liangliang Zhang, Kim-Anh Do, et al.
Journal of Transport & Health|September 13, 2021
An integrated approach to monitoring and estimating COVID-19 risk exposure among leisure-time physical activity participantsIngrid E Schneider, Greg Lindsey, Michael Petesch, et al.
Oncogene|October 5, 2021
RNA binding protein RBMS3 is a common EMT effector that modulates triple-negative breast cancer progression via stabilizing PRRX1 mRNAC James Block, Allison V Mitchell, Ling Wu, et al.
International Journal of Cancer|March 16, 2012
Induction of proapoptotic antibodies to triple-negative breast cancer by vaccination with TRAIL death receptor DR5 DNAMarie P Piechocki, Gen Sheng Wu, Richard F Jones, et al.
Pageof 3